Science & Enterprise subscription

Follow us on Twitter

  • The advocacy group Union of Concerned Scientists says space is an arena where most activity is for peaceful purpose… https://t.co/fs1QetgIws
    about 3 hours ago
  • New post on Science and Enterprise: Infographic – Countries with Most Space Satellites https://t.co/esIANqtGob #Science #Business
    about 3 hours ago
  • New contributed post on Science and Enterprise: https://t.co/Abq3ICK7BT Getting Into Auto Trading
    about 4 hours ago
  • A bioinformatics lab developed a prototype system for securely transmitting and storing clinical trial data with b… https://t.co/uXDzGN4Ezh
    about 20 hours ago
  • New post on Science and Enterprise: Blockchain Prototype Designed for Clinical Trial Data https://t.co/XNsa4huy1d #Science #Business
    about 20 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Companies Partner on High-Resolution 3-D Tissue Printer

Holograph-X bioprinter

Two developers of tissue engineering technologies are building a three-dimensional bioprinter that produces high resolution, finely structured human tissue, including tiny blood vessels. . . . → Read More: Companies Partner on High-Resolution 3-D Tissue Printer

Immune Cell Chips to Launch into Space for Microgravity Tests

Astronaut with tissue chip

Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station. . . . → Read More: Immune Cell Chips to Launch into Space for Microgravity Tests

Trial Results Show Gene Transfers Reverse Sickle Cell Disease

Gene therapy lab

Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year. . . . → Read More: Trial Results Show Gene Transfers Reverse Sickle Cell Disease

Janssen Licensing Cancer Antibodies in $1.8B Deal

Llama

An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal

Company Formed to Advance Sickle Cell Gene Therapy

Sickle cell illustration

A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders. . . . → Read More: Company Formed to Advance Sickle Cell Gene Therapy

3-D Printed Scaffolds with Stem Cells, Sensors Studied to Repair Bones

3-D printed bone scaffold

A bioengineering lab at University of Arizona is researching new techniques with three-dimensional printing, stem cells, and sensors to repair severe bone fractures. . . . → Read More: 3-D Printed Scaffolds with Stem Cells, Sensors Studied to Repair Bones

Engineered Tissue-Polymer Replacement Spinal Discs Developed

Spine model

Vertebrae discs made with engineered tissue from stem cells and biocompatible polymer hydrogels were shown in test with lab animals to have comparable properties to natural spinal discs. . . . → Read More: Engineered Tissue-Polymer Replacement Spinal Discs Developed

NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center

Cadmim leadership

A new federal grant supports expansion of a research and development center developing techniques to make the manufacture and integration of microfluidic, or lab-on-a-chip, devices easier and less expensive. . . . → Read More: NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center

NIH Award Supports Esophagus Tissue Implants from Stem Cells

Newborn

A company developing engineered tissue implants from stem cells received a grant from National Institutes of Health to develop an implant to correct a congenital defect in a newborn infant’s esophagus. . . . → Read More: NIH Award Supports Esophagus Tissue Implants from Stem Cells

NIH Stops Stem Cell Heart Failure Trial Over Retracted Data

Stop sign

National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle. . . . → Read More: NIH Stops Stem Cell Heart Failure Trial Over Retracted Data